Evidence map›Paper›PMID 28137745›Full record

ArticleGenome biology and evolution2017

Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa.

Koen Vandelannoote, Conor J Meehan, Miriam Eddyani, Dissou Affolabi, Delphin Mavinga Phanzu, Sara Eyangoh, Kurt Jordaens, Françoise Portaels, Kirstie Mangas, Torsten Seemann and 8 more

Abstract read
In one paragraph

Article in Genome biology and evolution, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Emergence and spread ofMicrobiology spectrum · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Human genetics of Buruli ulcer.Human genetics · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The changing epidemiology worldwide ofEpidemiology and infection · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Koen VandelannooteDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Conor J MeehanDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Miriam EddyaniDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Dissou AffolabiLaboratoire de Référence des Mycobactéries, Cotonou, Benin.
Delphin Mavinga PhanzuInstitut Médical Evangélique, Kimpese, Republic, Democratic of Congo.
Sara EyangohService de Mycobactériologie, Centre Pasteur du Cameroun, Yaoundé, Cameroun.
Kurt JordaensEvolutionary Ecology Group University of Antwerp, Antwerp, Belgium.
Françoise PortaelsDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Kirstie MangasDepartment of Microbiology and Immunology, University of Melbourne, Victoria, Australia.
Torsten SeemannVictorian Life Sciences Computation Initiative University of Melbourne, Victoria, Australia.
Laurent MarsollierCRCNA Inserm U892 CNRS 6299, CHU & Université d'Angers, Angers, France.
Estelle MarionCRCNA Inserm U892 CNRS 6299, CHU & Université d'Angers, Angers, France.
Annick ChautyCDTUB de Pobè, Pobè, Benin.
Jordi LandierService de Mycobactériologie, Centre Pasteur du Cameroun, Yaoundé, Cameroun.
Arnaud FontanetEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Herwig LeirsEvolutionary Ecology Group University of Antwerp, Antwerp, Belgium.
Timothy P StinearDepartment of Microbiology and Immunology, University of Melbourne, Victoria, Australia.
Bouke C de JongDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

European Research Council 311725
6 · The paper itself

Abstract

Buruli ulcer (BU) is an insidious neglected tropical disease. Cases are reported around the world but the rural regions of West and Central Africa are most affected. How BU is transmitted and spreads has remained a mystery, even though the causative agent, Mycobacterium ulcerans, has been known for more than 70 years. Here, using the tools of population genomics, we reconstruct the evolutionary history of M. ulcerans by comparing 165 isolates spanning 48 years and representing 11 endemic countries across Africa. The genetic diversity of African M. ulcerans was found to be restricted due to the bacterium's slow substitution rate coupled with its relatively recent origin. We identified two specific M. ulcerans lineages within the African continent, and inferred that M. ulcerans lineage Mu_A1 existed in Africa for several hundreds of years, unlike lineage Mu_A2, which was introduced much more recently, approximately during the 19th century. Additionally, we observed that specific M. ulcerans epidemic Mu_A1 clones were introduced during the same time period in the three hydrological basins that were well covered in our panel. The estimated time span of the introduction events coincides with the Neo-imperialism period, during which time the European colonial powers divided the African continent among themselves. Using this temporal association, and in the absence of a known BU reservoir or-vector on the continent, we postulate that the so-called "Scramble for Africa" played a significant role in the spread of the disease across the continent.

Indexed as

Evolution, MolecularGenetic VariationAfricaBuruli UlcerGenetics, PopulationGenome, BacterialHumansMycobacterium ulceransPhylogenyPolymorphism, Single NucleotideSequence Analysis, DNAbacterial pathogen transmissionmicrobial population genomicsmolecular evolutionphylogeography

Identifiers

PMID28137745
PMCPMC5381664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.